Hemosiderosis: Difference between revisions
No edit summary |
No edit summary |
||
(5 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Infobox_Disease | |||
| Name = {{PAGENAME}} | |||
| Image = | |||
| Caption = | |||
| DiseasesDB = 29717 | |||
| ICD10 = | |||
| ICD9 = {{ICD9|516.1}} | |||
| ICDO = | |||
| OMIM = 178550 | |||
| MedlinePlus = | |||
| MeshID = | |||
}} | |||
{{Hemosiderosis}} | {{Hemosiderosis}} | ||
{{CMG}} | {{CMG}} [[Roghayeh Marandi]] | ||
{{SK}} Idiopathic | {{SK}} Idiopathic pulmonary hemosiderosis; IPH; hemosiderin accumulation; Pulmonary hemosiderosis; Pulmonary haemosiderosis; Essential brown induration of lung; Brown induration of lung; Ceelen-Gellerstedt syndrome | ||
==[[ | ==[[Hemosiderosis overview|Overview]]== | ||
==[[ | ==[[Hemosiderosis historical perspective|Historical Perspective]]== | ||
==[[ | ==[[Hemosiderosis classification|Classification]]== | ||
==[[ | ==[[Hemosiderosis pathophysiology|Pathophysiology]]== | ||
==[[ | ==[[Hemosiderosis causes|Causes]]== | ||
==[[ | ==[[Hemosiderosis differential diagnosis|Differentiating Hemosiderosis from other Diseases]]== | ||
==[[ | ==[[Hemosiderosis epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Hemosiderosis risk factors|Risk Factors]]== | |||
==[[Hemosiderosis screening|Screening]]== | |||
==[[Hemosiderosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
==Diagnosis== | ==Diagnosis== | ||
[[ | [[Hemosiderosis history and symptoms|History and Symptoms ]] | [[ Hemosiderosis physical examination|Physical Examination]] | [[Hemosiderosis laboratory findings|Laboratory Findings]] | [[Hemosiderosis electrocardiogram|Electrocardiogram]] | [[Hemosiderosis chest x ray|Chest X Ray]] | [[Hemosiderosis CT|CT]] | [[Hemosiderosis MRI|MRI]] | [[Hemosiderosis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Hemosiderosis other imaging findings|Other Imaging Findings]] | [[Hemosiderosis other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[ | [[Hemosiderosis medical therapy|Medical Therapy]] | [[Hemosiderosis surgery |Surgery]] | [[Hemosiderosis primary prevention|Primary Prevention]] | [[Hemosiderosis secondary prevention|Secondary Prevention]] | [[Hemosiderosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hemosiderosis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[ | [[Hemosiderosis case study one|Case #1]] | ||
== Related Chapters == | == Related Chapters == | ||
* [[Transfusion hemosiderosis]] | * [[Transfusion hemosiderosis]] |
Latest revision as of 08:15, 28 September 2020
Hemosiderosis | |
ICD-9 | 516.1 |
---|---|
OMIM | 178550 |
DiseasesDB | 29717 |
Hemosiderosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hemosiderosis On the Web |
American Roentgen Ray Society Images of Hemosiderosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Roghayeh Marandi
Synonyms and keywords: Idiopathic pulmonary hemosiderosis; IPH; hemosiderin accumulation; Pulmonary hemosiderosis; Pulmonary haemosiderosis; Essential brown induration of lung; Brown induration of lung; Ceelen-Gellerstedt syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemosiderosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies